Who We Are
Biologics by McKesson specialty pharmacy is a leader in creating truly exceptional patient experiences by simplifying connections for providers and delivering personalized care for every patient who we have the honor of serving.
We Focus on Our Patients
At Biologics, we focus on why we do what we do: our patients and the partners we work with. As an independent specialty pharmacy, we specialize in cancer and rare disease areas. Our goals are to simplify access to therapies and deliver personalized clinical care that helps patients understand how to take their medication, manage side effects and achieve the best-possible outcomes. We also provide benefits investigation, assist with prior authorizations and help patients find financial aid so they can afford their treatment.
Take a look at what our patients have to say about their experience with us.
Setting the Standard
With over 25 years’ experience caring for patients with cancer and other complex and rare diseases, Biologics has a strong foundation of clinical care with our multidisciplinary care team, and we’ve built on that approach by layering in partnerships, programs and technology that allow us to further elevate the way we care for our patients and the access we can provide them.
What can we help you with today?
For Patients
Quick delivery, financial aid, side-effect management and adherence support.
For Providers
Fast time to first fill, customized solutions and exceptional patient care.
For Biopharma
Fast time to first fill, provider engagement and patient adherence.
For Payers
Cost management, industry-leading access and clinical care.
Biologics by McKesson News
OJJAARA (momelotinib), FDA Approved for the Treatment of Myelofibrosis in Adults with Anemia, Available at Biologics by McKesson
CARY, N.C., Sept. 20, 2023—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by GSK as a specialty pharmacy provider for...
VANFLYTA (quizartinib), FDA Approved in the U.S. for Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia, Available at Biologics by McKesson
CARY, N.C., Aug. 4, 2023 — Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by Daiichi Sankyo, Inc., as a specialty...
Biologics by McKesson Named the Exclusive Pharmacy for FDA- Approved SKYCLARYS (omaveloxolone) for the Treatment of Friedreich’s Ataxia
CARY, N.C., April 5, 2023 — Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by Reata Pharmaceuticals as the sole specialty...